Cover
Vol. 13 No. 1 (2023)

Published: May 31, 2023

Pages: 60-72

Research Article

Single Dose of Granulocyte-Colony Stimulating Factor Use to Improve Outcomes in Patient Undergoing Intracytoplasmic Sperm Injection

Aseel ALFil 1 Lubna A. AL-Anbari
1High Institute of Infertility Diagnosis and Assisted Reproductive Technologies, Al-Nahrain University, Baghdad, Iraq.
History
  • Received: April 7, 2023
  • Accepted: April 30, 2023
  • Available Online: May 8, 2023
DOI

https://doi.org/10.28969/IJEIR.v13.i1.r5.23

Abstract

Receptive endometrium is essential for successful embryo implantation and is created by the synergistic activities of estrogen and progesterone, as well as support from other endocrine, paracrine, and autocrine pathways. Granulocyte Colony Stimulating Factor (G-CSF) may play a crucial role in modulating the immune response to enhance implantation. To estimate the role of granulocyte-colony stimulating factor on the clinical intracytoplasmic sperm injection (ICSI) outcome parameters. A prospective comparative study with random sample selection was carried out from 2021 to 2023 at the High Institute for Infertility Diagnosis and Assisted Reproductive Technologies, Al-Nahrain University. It included 80 women with infertility, with or without previous failure trials of intracytoplasmic sperm injection, who completed IVF and ICSI protocols and reached the day of embryo transfer. On the day of embryo transfer, patients were divided into two groups: 49 patients received no additional treatment (group 1), and 31 patients received granulocyte-colony stimulating factor subcutaneous injection within one hour of embryo transfer (group 2). The implantation rate was 13.3% in group 2 compared to 7.6% in group 1. The chemical and clinical pregnancy rates were 29.0% and 25.8% in group 2, while group 1 had 18.4% for both chemical and clinical pregnancy rates. The pregnancy and implantation rates were slightly higher in group 2, but the difference was not significant. More research is needed to support the use of G-CSF as a standard treatment in ICSI patients.

Keywords

References

  1. Hameed, A.M., Abood, M.S., Ghazi, H.F. and Al-Anbari, L., ‘Evaluation of Soluble L- Selectin (CD 62L) Level in Embryo Culture Media to Embryo Quality and Implantation Rate’, Iraqi Journal of Embryos and Infertility Researches, 2018 Jan. 8 (2). DOI:10.28969/IJEIR.v8.i2.r2
  2. Remião, M.H., Segatto, N.V., Pohlmann, A., Guterres, S.S., Seixas, F.K. and Collares, T. The potential of nanotechnology in medically assisted reproduction, Frontiers in Pharmacology, 2018, Jan 8, p. 1–9. DOI: 10.3389/fphar.2017.00994.
  3. Yousif, A. A. A., Jwad, M. A. and Al-Hilli, N. ‘Glycotoxins Relationship with Body Mass Index (BMI),’ Iraqi Journal of Embryos and Infertility Researches, 2020, Dec. 10 (1), pp. 51–66. DOI: https://doi.org/10.28969/IJEIR.v10.i1.r 4
  4. Ali, A. A., Jawad, M. A. and Al-Hilli, N. ‘Evaluation of Serum and Follicular Fluid Levels of Advanced Glycation End products (AGEs) on ICSI Outcome,’ Prensa Med Argent, 2020, May.109 (4) pp. S1-003.
  5. Cunha, A. and Póvoa, A. M. ‘Infertility management in women with polycystic ovary syndrome: a review,’ Porto Biomedical Journal, 2021, Jan 6 (1), p. e116. DOI: 10.1097/j.pbj.0000000000000116.
  6. Noël, L., Fransolet, M., Jacobs, N., Foidart, J.M., Nisolle, M. and Munaut, C.‘A paracrine interaction between granulosa cells and leukocytes in the preovulatory follicle causes the increase in follicular G-CSF levels’, Journal of Assisted Reproduction and Genetics, 2020, Feb 37 (2), pp. 405–416. DOI: 10.1007/s10815-020-01692-y.
  7. Faisal, Al-Kawaz, U., Al-Anbari, L. and Hussaini, H., ‘Evaluation of the Level of Stem Cell Factor in Follicular Fluid and its Effect on Oocyte Maturity, Embryo Quality, and Pregnancy Rate,’ Iraqi Journal of Embryos and Infertility Researches, 2020, May. 9 (2), p. 65–77. DOI: https://doi.org/10.28969/IJEIR.v9.i2.r5
  8. Altmäe, S. and Aghajanova, L. ‘Growth hormone and endometrial receptivity,’ Frontiers in Endocrinology, 2019, Sep. 10 DOI: 10.3389/fendo.2019.00653.
  9. Alvarez, K.L.F., Beldi, M., Sarmanho, F., Rossetti, R.A.M., Silveira, C.R.F., Mota, G.R., Andreoli, M.A., Caruso, E.D.D.C., Kamillos, M.F., Souza, A.M. and Mastrocalla, H., ‘Local and systemic immunomodulatory mechanisms triggered by Human Papillomavirus transformed cells: A potential role for G-CSF and neutrophils’, Scientific Reports, 2017, Jul, 7 (1), p. 1–16. DOI: 10.1038/s41598-017-09079-3.
  10. Cavalcante, M.B., Costa, F.D.S., Barini, R. and Júnior, E.A. ‘Granulocyte colony- stimulating factor and reproductive medicine: A review,’ Iranian Journal of Reproductive Medicine, 2015, Apr. 13 (4), p. 195–202.
  11. Kamath, M. S., Kirubakaran, R. and Sunkara, S. K. ‘Granulocyte-colony stimulating factor administration for subfertile women undergoing assisted reproduction,’ Cochrane Database of Systematic Reviews, 2018 Dec. (12). DOI: 10.1002/14651858.CD013226.
  12. Würfel, W., ‘Treatment with granulocyte colony-stimulating factor in patients with repetitive implantation failures and/or recurrent spontaneous abortions,’ Journal of Reproductive Immunology, 2015, Apr. 108, p. 123–135. DOI: 10.1016/j.jri.2015.01.010
  13. Kalem, Z., Namli Kalem, M., Bakirarar, B., Kent, E., Makrigiannakis, A. and Gurgan, T., ‘Intrauterine G-CSF Administration in Recurrent Implantation Failure (RIF): An Rct,’ Scientific Reports, 2020, Mar.10 (1), p. 1–7. DOI: 10.1038/s41598-020-61955-7.
  14. Michikawa, T., Morokuma, S., Yamazaki, S., Takami, A., Sugata, S., Yoshino, A., Takeda, Y., Nakahara, K., Saito, S., Hoshi, J. and Kato, K. Exposure to chemical components of fine particulate matter and ozone, and placenta-mediated pregnancy complications in Tokyo : a register-based study’,2022, Jan. 32 (1) p. 135–145. DOI: 10.1038/s41370-021-00299-4.
  15. Eftekhar, M., Mohammadi, B., Mangoli, E. and Mortazavi, M., ‘Is there any correlation between estradiol supplementation, as luteal phase support, and clinical pregnancy in art cycles? A cross-sectional study, International Journal of Reproductive BioMedicine, 2020, Nov. 18 (11), p. 969–974. DOI: 10.18502/ijrm.v13i11.7964.
  16. Li, X., Zeng, Y., He, J., Luo, B., Lu, X., Zhu, L., Yang, Z., Cai, F., Chen, S.A. and Luo, Y., ‘The optimal FET strategy for the recurrent implantation failure patient: thawing Day 3 embryos and culturing to Day 5 blastocysts. Fertility and Sterility.2022, Jun.
  17. Martin, K.R., Wong, H.L., Witko-Sarsat, V. and Wicks, I.P. ‘A double edge sword in neutrophil-mediated immunity. Semin Immunol. 2021 Apr; 54:101516. DOI: 10.1016/j.smim.2021.101516.
  18. Banerjee, K., Singla, B. and Verma, P. ‘Efficacy of subcutaneous granulocyte colony-stimulating factor infusion for treating thin endometrium,’ Clinical and Experimental Reproductive Medicine, 2022, Mar. 49 (1),p. 70–73. DOI: 10.5653/cerm.2021.04833
  19. Kashani, L., Moini, A., Esfidani, T., Yamini, N. and Mohiti, S., ‘Effect of intrauterine granulocyte-colony stimulating factor administration on in vitro fertilization outcome in women with moderate-to-severe endometriosis: An rct,’ International Journal of Reproductive BioMedicine,2021, Aug. 19 (8),p.733–740. DOI: 10.18502/ijrm.v19i8.9621.
  20. Jiang, L., Qian, Y., Chen, X., Ji, X., Ou, S., Li, R., Yang, D. and Li, Y. ‘Effect of early rescue ICSI and split IVF‐ICSI in preventing low fertilization rate during the first ART cycle: A real‐world retrospective cohort study’, Reproductive medicine and biology, 2022, Dec. 21 (1), p. e12420. DOI: 10.1002/rmb2.12420
  21. Wu, W., Xu, G.-F. and Hu, Y.-J. ‘The therapeutic effect of granulocyte colony- stimulating factor (G-CSF) on potential biochemical pregnancy in patients with unexplained repeated transplantation failure (RIF): a case series and literature review,’ Gynecological Endocrinology, 2022, May 38 (5), p. 443–447. DOI: 10.1080/09513590.2022.2036716
  22. Al-Jubouri, W. M., Al-Obaidi, M. T. and Hussaini, H. A. ‘Endometrial perfusion with granulocyte colony-stimulating factor in infertile women,’ Pharmacology online, 2021, Aug.,2, p. 417–425.
  23. Zhang, A.W., Morjaria, S., Kaltsas, A., Hohl, T.M., Parameswaran, R., Patel, D., Zhou, W., Predmore, J., Perez-Johnston, R., Jee, J. and Daniyan, A.F. ‘The Effect of Neutropenia and Filgrastim (G-CSF) on Cancer Patients With Coronavirus Disease 2019 (COVID-19) Infection’, Clinical Infectious Diseases, 2022, Mar, 74 (4),p. 567– 574. DOI: 10.1093/cid/ciab534
  24. Rawlings, T.M., Makwana, K., Taylor, D.M., Molè, M.A., Fishwick, K.J., Tryfonos, M., Odendaal, J., Hawkes, A., Zernicka- Goetz, M., Hartshorne, G.M. and Brosens, J.J, ‘Modelling the impact of decidual senescence on embryo implantation in human endometrial assembloids,’ Elife, 2021 Sep 6;10:e69603. DOI: 10.7554/eLife.69603.
  25. Ojosnegros, S., Seriola, A., Godeau, A.L. and Veiga, A., ‘Embryo implantation in the laboratory: an update on current techniques,’ Human Reproduction Update,2021, Apr. 27 (3), p. 501–530. DOI: 10.1093/humupd/dmaa054
  26. Maksym, R.B., Hoffmann- Młodzianowska, M., Skibińska, M., Rabijewski, M., Mackiewicz, A. and Kieda, C. ‘Immunology and immunotherapy of endometriosis,’ Journal of Clinical Medicine, 2021, Dec. 10 (24),p. 1–12. DOI: 10.3390/jcm10245879.
  27. Kolanska, K., Alijotas‐Reig, J., Cohen, J., Cheloufi, M., Selleret, L., D’argent, E., Kayem, G., Valverde, E.E., Fain, O., Bornes, M. and Darai, E., ‘Endometriosis with infertility: A comprehensive review on the role of immune deregulation and immunomodulation therapy,’ American Journal of Reproductive Immunology,2021, Mar. 85 (3), p. 0–3. DOI: 10.1111/aji.13384.
  28. Günther, V., Otte, S.V., Freytag, D., Maass, N. and Alkatout, I., ‘Recurrent implantation failure–an overview of current research,’ Gynecological Endocrinology, 2021, Jul. 37 (7), p. 584–590. DOI 10.1080/09513590.2021.1878136.
  29. Torky, H., El-Desouky, E.S., El-Baz, A., Aly, R., El-Taher, O., Shata, A., Hussein, A., Marie, H., Deif, O., Eldemery, A. and Abo- Louz, A. ‘Effect of intrauterine granulocyte colony-stimulating factor vs. human chorionic gonadotropin at ovum pick up day on pregnancy rate in IVF/ICSI cases with recurrent implantation failure,’ JBRA Assisted Reproduction, 2022, Apr. 26 (2), p.274. DOI 10.5935/1518-0557.20210056.
  30. Maneta, E., Fultang, L., Taylor, J., Pugh, M., Jenkinson, W., Anderson, G., Coomarasamy, A., Kilby, M.D., Lissauer, D.M., Mussai, F. and De Santo, C ‘G‐CSF induces CD15+ CD14+ cells from granulocytes early in the physiological environment of pregnancy and the cancer immunosuppressive microenvironment’, Clinical & Translational Immunology,2022, 11 (5), p.e1395.